Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and amphotericin b

quinazolines has been researched along with amphotericin b in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castaldo, RA; Gump, DW; McCormack, JJ1
Capilla, J; Guarro, J; Javier Pastor, F; Ortoneda, M; Pujol, I1
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C1
Abuelizz, HA; Al-Salahi, R; Alotaibi, MA; El Dib, RA; Marzouk, M; Wadi, M1
Feiz Barazandeh, A; Jia, P; Keynan, Y; Khadem, F; Liu, D; Mou, Z; Uzonna, JE1
Amer, A; Asal, AM; Bekhit, AA; El-Faham, A; Guemei, AA; Haiba, NS; Khattab, SN1

Other Studies

6 other study(ies) available for quinazolines and amphotericin b

ArticleYear
Activity of 2,4-diaminoquinazoline compounds against Candida species.
    Antimicrobial agents and chemotherapy, 1979, Volume: 15, Issue:1

    Topics: Amphotericin B; Animals; Candida; Drug Resistance, Microbial; Drug Stability; Flucytosine; Mice; Quinazolines

1979
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
    Diagnostic microbiology and infectious disease, 2004, Volume: 48, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Resistance, Fungal; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Quinazolines; Sensitivity and Specificity; Terbinafine; Thiazoles; Triazoles; Voriconazole

2004
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:12

    Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole

2006
Antimicrobial Activity of Synthesized 2-Methylthiobenzo[g][1,2,4]- triazolo[1,5-a]quinazoline Derivatives.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2016, Volume: 12, Issue:8

    Topics: Amphotericin B; Ampicillin; Anti-Bacterial Agents; Antifungal Agents; Colony Count, Microbial; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mitosporic Fungi; Quinazolines; Triazoles

2016
Pharmacological inhibition of p110δ subunit of PI3K confers protection against experimental leishmaniasis.
    The Journal of antimicrobial chemotherapy, 2017, Volume: 72, Issue:2

    Topics: Adenine; Amphotericin B; Animals; CD4 Lymphocyte Count; Class I Phosphatidylinositol 3-Kinases; Cytokines; Drug Therapy, Combination; Female; Immunomodulation; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liver; Lymph Nodes; Mice; Mice, Inbred BALB C; Parasite Load; Phosphoinositide-3 Kinase Inhibitors; Purines; Quinazolines; Quinazolinones; Spleen; T-Lymphocytes, Regulatory

2017
Study of antileishmanial activity of 2-aminobenzoyl amino acid hydrazides and their quinazoline derivatives.
    Bioorganic & medicinal chemistry letters, 2017, 02-15, Volume: 27, Issue:4

    Topics: Amino Acids; Amphotericin B; Antiprotozoal Agents; Deoxycholic Acid; Drug Combinations; Inhibitory Concentration 50; Isomerism; Leishmania; Magnetic Resonance Spectroscopy; Molecular Conformation; Phosphorylcholine; Quinazolines; Structure-Activity Relationship

2017